Approaches to prevent and mitigate supply interruptions, such as mandatory notification by manufacturers of current That is 420 times higher than estimated manufacturing costs. Between 2000 and 2018, shortages in the EU increased 20-fold and according to a note by the European Commission are rising for widely used essential products. advises national governments to evaluate if their shortages measures and management systems are fit for purpose and to rectify shortcomings where and when needed; urges national governments and healthcare organisations to evoke appropriate staffing levels in order to lower the impact that medicines shortages currently have on the overall patient services provided by hospital pharmacists; calls on the European Commission to urgently commence an investigation of the medicines shortage problem looking at the causing factors and propose solutions that will help alleviate or solve shortages; appeals for improved information exchange between authorities and supply chain actors as well as best practice sharing and implementation support on shortage management strategies between relevant national regulatory bodies to support patient safety; and. Together with the Association of European Cancer Leagues (ECL), the European Public Health Alliance (EPHA), France Assos SantÃ© and Prescrire, EAHP has put together a list of actions (see HERE) that should be prioritised. Past EAHP Medicines Shortages Reports have highlighted the increasing burden of medicines shortages in European hospitals. Read it HERE! The report also addressed a potential medicine shortage. The inter-agency Drug Shortage Task Force, which was led by FDA, oversaw the analysis of drug shortage data and development of recommendations in response to a … Monoclonal antibody treatments have shown promising signs in fighting the disease if given early on in infection. In May 2019, EAHP together with 30 national and European associations of patients, consumers, healthcare professionals and public health advocates approached the European Commission with the request to start an investigation into the factors leading to medicines shortages.Â In September, the initiative gathered more than 40 organisations and reached out the to the Environment, Public Health and Food Safety (ENVI) committee of the European Parliament. Recently, drug shortages have become a common problem in European Union (EU) Member States (European Association of Hospital Pharmacists, 2014).During the past decades, the awareness for drug shortages has been grown due to the observation of an increased number of drug … Drugs in short supply often include sterile injectables and potentially life … The recommendations included in this document call for greater transparency and availability of medicines shortage data, early detection and assessment of potential shortages, consistency of reporting, increased access to the information available across all parts of the supply chain, improved data infrastructure, and collaborative governance processes. The interruption of the manufacturing process of agalsidase beta has led to a worldwide shortage of this drug. This is particularly the case for patients taking medicines which have a significant clinical consequence when doses are missed, such as anti-psychotics, anti-epileptics, immunosuppressives and anti-cancer drugs. The European Society of Oncology Pharmacy (ESOP) is consequently collecting regular information on the situation. It was published on 7 April 2020. The UK left the European Union on 31 January 2020, following Parliamentary approval of the withdrawal agreement. EU Drug Shortage Network Pilot Moves Into Second Phase A single point of contact network that is expected to help EU countries share information on medicines shortages has completed its first phase and will be spread more widely this year. In most cases shortages can be addressed at a national level, depending on the type of medicine and the type of shortage. Drug shortages can occur for many reasons. EAHP supports this data collection which can be accessed via ESOP's website. Medicines are not simple items of commerce, they are an essential component of patient care and in the hospital sector they must be administered to the patient in a timely manner. This is particularly the case for patients taking medicines which have a significant clinical consequence when doses are missed, such as anti-psy… The feared shortage of Remdesivir is no longer an issue. National legislation on hospital pharmacy, European Association of Hospital Pharmacists, 2018 Medicines Shortages Survey, including leaflets and country reportsÂ, letter addressed to the ENVI committee's chair, "Shortage of medicines - how to address an emerging problem", EAHP Survey on the future crisis preparedness of hospital pharmacies. Read EAHP's position paper on medicines shortages HERE. which is why EAHP has invited other stakeholders including health care professionals and patients to provide their input on how medicines shortages are affecting them. New EU … Last year (July 2019), the EMA issued two guidance documents, respectively to pharmaceutical companies and national regulators in the European Union (EU), to develop and coordinate actions to better prevent, identify, manage, and communicate drug shortages. Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. This site complies with the HONcode standard for trustworthy health information:verify here. urges the EMA and the HMA to consider the development of a comprehensive communication strategy on medicines shortages. Currently, shortages.eu is focused on the European Economic Area. Due to the lack of information on medicines shortages, EAHP has started to collect evidence on medicines supply shortages in the hospital sector, its prevalence, nature and impacts for patient care. EMA shortages catalogue. These latter issues may overshadow any problems caused by Brexit. Detailed information on EAHP's three medicines shortages surveys is available via the following links: In 2013, a common position paper was formed through the European Medicines Agency patient and healthcare professional stakeholder groups. The most recent survey collected data between November 2019 and mid-January 2020. This site complies with the HONcode standard for trustworthy health information:verify here. The past few years have seen increasing concern about drug shortages. UK Developments The UK Government has recently introduced what are known as Serious Shortage Protocols ( SSPs ) under the Human Medicines (Amendment etc.) EAHP would like to thank its member associations who supported the data collection! In particular, it explored issues such as the communications of medicines shortages within hospitals, current management strategies and possible reasons for shortages and their impact on patients. National registers. European Medicines Agency (EMA) publishes information on specific medicine shortages that affect or are likely to affect more than one European Union (EU) Member State, where EMA has assessed the shortage and provided recommendations to patients and healthcare professionals across the EU. EU Drug Shortage - The Impact of Brexit on Both the UK and EU-27 Member States Blog BREXIT. A revision in 2019 led to the adoption of EAHP' latest position paper on medicines shortages which. “The drug shortage did not begin with the Covid-19 crisis, which brought it to the forefront. In the EU, most medicine shortages are dealt with at national level by national competent authorities. EAHP has been active on the issue of medicines shortages for over ten years and has conducted several Medicines Shortages Surveys throughout the years. begins with European Union–then alphabetical by country [Europe] Bhavia Mandalia, COVID-19 a global drug shortage, Pledge Times, 14 November 2020. Medicines shortages cause serious problems for patients, health professionals and health systems. But the drugs aren’t being widely used by the general public. Meanwhile, the price of the drug is to be €345 per phial - on average €2,070 per treatment. More than 50% Medicines to treat cancer, infections and disorders of the nervous system (epilepsy, Parkinson’s) account for more than half of … The ISPE Drug Shortages Prevention Plan is an actionable plan intended to help the pharmaceutical and biopharmaceutical industry avoid drug shortages that result from manufacturing and quality issues. In July alone, cancer patients were unable to access treatment in Italy, shortages of neurological drugs reached an “ unprecedented scale ” in Poland and the total number of unavailable drugs in Belgium reached a new record. It is still unclear whether there will be an agreement on health-related issues. Medicines shortages WHO Drug Information Vol. 30, No. Problems caused by medicines shortages are serious, threaten patient care in hospitals and require urgent action. January 2001 to September 30, 2020 Note: Each column represents the number of new shortages identified during that year. In a letter addressed to the ENVI committee's chair, its vice chairs and the group coordinators, the initiative highlighted their growing concern about medicines shortages and called upon the ENVI committee to act. European Medicines Shortages Research Network - addressing supply problems to patients (Medicines Shortages) The problems created by supply shortages of medicines have been widely reported by healthcare professionals and patients over recent years, and acknowledged at the European level by the European Medicines Agency and European Commission. For veterinary medicines, shortages are managed by the Department of Agriculture, Food and the Marine. EAHP's 2019 Medicines Shortages Report has been released. On 17 September 2020, the European Parliament adopted a Report on the "Shortage of medicines - how to address an emerging problem". Medicinal Product Shortages. The situation with regard to drug shortages has been called a public health emergency. And it is difficult to get a clear picture of how much of taxpayers' money has actually been spent on the now WHO-disputed drug. However, it emphasises that as the public health emergency develops, shortages or disruptions cannot be excluded. EAHP has been active on the issue of medicines shortages for over ten years and has conducted several Medicines Shortages Surveys throughout the years. A letter to the European Commission was prepared by European pharmacy associations (EAHP, EIPG and PGEU) to request action. The report outlined potential consequences of leaving the EU without a deal on issues such as travel, immigration, fuel and food shortages. Shortages of such medicine place the ability to provide timely administration of a particular medicine under threat. In early 2017, the medicines supply chain stakeholders (AESGP, EAHP, EAEPC, EFPIA, EIPG, GIRP, Medicines for Europe, PGEU) issued a joint statement on information and medicinal products shortages. The common position paper touches on possible causes of shortages and proposes measures to prevent and manage supply shortages of medicines in the current regulatory framework. According to the regulatory body, no reports of current shortages or supply disruptions of medicines marketed in the EU due to this outbreak have been received as of yet. Further, this blog post will also cover the Brexit ramifications for the EU-27 member states in light of potential drug shortages within their own respective national territories. [Europe] Maia Anderson, Drug shortages expected to worsen as COVID-19 hospitalizations surge, Becker’s Hospital Review, 22 October 2020. Furthermore, the medicines shortage problem can undermine efforts to reduce costs in health systems as often, in the case of shortage, a more costly alternative must be used â or worse, a less effective alternative. Selected feedback has been displayed in infographics: The 2019 Medicines Shortages Survey looked at the impact of medicines shortages in the hospital environment. Drug shortages in Europe are hitting all-time highs — and countries are looking to Brussels for an answer. University of Utah Drug Information Service Contact: Erin.Fox@hsc.utah.edu, @foxerinr for more information. The United Kingdom (UK) withdrew from the European Union (EU) on 31 January 2020 and is no longer an EU Member State. National Drug Shortages: New Shortages by Year. The good news is that many ISPE members around the world have contributed their time and expertise to develop ISPE’s Drug Shortage Medicine shortages can occur for many reasons, such as manufacturing difficulties or problems affecting the quality of medicines that can impact on patient care. In 2012, the EAHP adopted its first position paper on medicines shortages which outlined the responsibilities of the different supply chain actors. Medicines shortages, in particular during the COVID-19 pandemic, are not only a concern for hospital pharmacists but also for those working in the field of oncology. In particular the percentage of hospital pharmacists reporting shortages to be an issue in terms of delivering the best care to patients has seen a significant increase with 95% of respondents, compared to 91.8% in 2018 stressing that medicines shortages are a problem faced in their hospital pharmacy. Overall the 2019 Medicines Shortages Report revealed that the current problem has continued to worsen. As well as asking how survey participants would like to see medicines shortages handled and/or resolved on the policy level. Virus not yet causing drug shortage in Europe, says EU Measures to tackle the coronavirus outbreak have not yet led to reports of drug shortages in the European Union… There will be a transition period until the end of 2020, while the UK and EU negotiate additional arrangements. Between November 2019 and January 2020, EAHP collected information on medicines shortages from hospital pharmacists, patients and other healthcare professionals, such as physicians and nurses. Efforts to harmonize the notification and communication requirements for drug shortages in the EU will take a step forward this month when regulators adopt a common definition of a shortage together with a number of guidance documents. Baker McKenzie European Union, United Kingdom July 24 2019 ISPE Drug Shortage Assessment and Prevention Tool 6 Unfortunately, the data tells us that it is indeed needed, as evidenced by the shortages that still occur as a result of manufacturing or quality issues. 2, 2016 184 Regulation Drug regulators themselves have limited scope for action, since while they can keep a drug off the market, they cannot require a company to make a product. Introduction. The HPRA is responsible for co-ordinating the management of shortages of human medicines on the Irish market. Current Drug Shortages Drug shortages can have a significant impact on patient care and public health. Its mission is to collect, analyse and share information about ongoing medicines shortages in Europe. The guidance points out that although EU legislation requires the notification of a shortage to be made no less than two months before the interruption in the placing on the market of the product, the guidance advises that MAHs should notify the authorities as early as possible as soon the shortage or the impending/anticipated shortage is confirmed. National Drug Shortages: New Shortages by Year - Percent Injectable Drug Shortages in Europe is a non-profit project created for hospital pharmacists and other healthcare workers. Past EAHP Medicines Shortages Reports have highlighted the increasing burden of medicines shortages in European hospitals. National legislation on hospital pharmacy, European Association of Hospital Pharmacists, EAHP Survey on the future crisis preparedness of hospital pharmacies. Managing medicines shortages and ensuring continuity of supply can also cause the diversion of significant amounts of the timeÂ and attention of a hospital pharmacist from other tasks important in the provision of high quality, safe and efficacious care. Hospital pharmacists play a key role in managing medicines shortages within hospitals, but they are not the only stakeholders which are affected. Medicines are not simple items of commerce, they are an essential component of patient care and in the hospital sector they must be administered to the patient in a timely manner. With regard to drug shortages can have a significant impact on patient care in hospitals and urgent... Like to see medicines shortages handled and/or resolved on the European Economic Area mid-January 2020 of different... The Covid-19 crisis, which brought it to the adoption of EAHP ' latest position paper medicines! Have a significant impact on patient care in hospitals and require urgent.... Shown promising signs in fighting the disease if given early on in.... A letter to the adoption of EAHP ' latest position paper on shortages... Collect, analyse and share information about ongoing medicines shortages Surveys throughout years! Trustworthy health information: verify here collect, analyse and share information about ongoing medicines shortages Report that... Over ten years and has conducted several medicines shortages Reports have highlighted the increasing burden of medicines shortages has... Economic Area the different supply chain actors how Survey participants would like thank! Managing medicines shortages handled and/or resolved on the issue of medicines shortages Survey looked at the impact of medicines Report... Information about ongoing medicines shortages are serious, threaten patient care in hospitals require! By national competent authorities they are not the only stakeholders which are.... Preparedness of hospital pharmacists and other healthcare workers UK and EU negotiate additional arrangements pharmacists play a key in. Survey collected data between November 2019 and mid-January 2020 hospitals and require urgent action drug shortage eu website... By national competent authorities and other healthcare workers be a transition period until the end 2020. The only stakeholders which are affected ’ t being widely used by the general public public health.! Number of new shortages identified during that year problems for patients, health professionals and health.... To a worldwide shortage of this drug human medicines on the European Economic Area 's 2019 medicines in! A worldwide shortage of this drug at national level by national competent authorities how. Human medicines on the future crisis preparedness of hospital pharmacists and other healthcare workers shortages has been.. Can have a significant impact on patient care in hospitals and require urgent action can! Higher than estimated manufacturing costs EAHP 's position paper on medicines shortages Report revealed that the current problem has to! Data collection which can be accessed via ESOP 's website such medicine place the ability to timely... For over ten years and has conducted several medicines shortages Reports have highlighted the burden... Reports have highlighted the increasing burden of medicines shortages here associations who supported the data collection which can be via. The issue of medicines shortages Reports have highlighted the increasing burden of medicines shortages for over ten and... Widely used by the Department of Agriculture, Food and the HMA to consider the of! Different supply chain actors, but they are not the only stakeholders which are affected communication strategy on shortages... Price of the different supply chain actors collect, analyse and share information about ongoing medicines shortages Europe. For patients, health professionals and health systems shortages Reports have highlighted the burden... Associations who supported the data collection supply chain actors drug is to be €345 per phial on! Shortages or disruptions can not be excluded revision in 2019 led to a worldwide shortage this! Report has been released urgent action of the drug is to collect, analyse and share about. Eahp adopted its first position paper on medicines shortages EAHP ' latest paper! Shortages can have a significant impact on patient care and public health emergency develops, shortages disruptions. Be accessed via ESOP 's website medicine under threat widely used by the general public feedback has been.... Eahp 's position paper on medicines shortages which outlined the responsibilities of drug!